The flow cytometry-based test is the first available for the firm's FlowScript platform and allows for the simultaneous analysis of multiple genes expressed in a single cell.
NEW YORK (GenomeWeb) – Enzo Biochem today said that PerkinElmer will pay the firm $7 million as part of a legal settlement reached between the firms last week.
NEW YORK (GenomeWeb News) – Enzo Biochem reported after the close of the market Tuesday that its second quarter revenues increased 3 percent year over year, with growth posted for both its life sciences products and clinical lab services.
NEW YORK (GenomeWeb News) – Enzo Clinical Labs and Nuclea Biotechnologies have entered into an agreement to market Nuclea's non-invasive HER-2/neu serum test for monitoring metastatic breast cancer, Enzo Biochem announced today.
NEW YORK (GenomeWeb News) – Enzo Biochem today said that a federal court has awarded the firm an additional $12.4 million in prejudgment interest in connection with a November 2012 jury verdict which found that Life Technologies infringed Enzo's patents.
NEW YORK (GenomeWeb News) – Enzo Biochem today said that it has signed an agreement to market Sequenom's MaterniT21 Plus test service in the northeast US.
The SARS-CoV-2 variant uncovered in California may be more transmissible and partially evade vaccine-induced antibody response, the Los Angeles Times reports.
